R. Eliakim et al., Sulphydryl blocker-induced rat colitis is ameliorated by intravenous injection of antibody to colonic surfactant-like particle, INFLAMM B D, 5(1), 1999, pp. 16-23
A rat model of experimental colitis and jejunitis induced by iodoacetamide
(IA), a sulphydryl blocker is accompanied by increased leukotriene, prostag
landin E-2 (PGE(2)) generation, and nitric oxide synthase (NOS) activity. R
at small intestinal and colonic surfactant-like particles (SLP) that accumu
late on the apical surface of mucosal cells have been identified and specif
ic antibodies to them have been produced. The aim of this study was to eval
uate a possible role of SLP in IA-induced colitis and jejunitis. Inflammati
on was induced in Sprague-Dawley rats either by intracolonic administration
of 3% IA (0.1 ml) or by intrajejunal administration of 2% IA (0.1 mi. Anti
sera raised against either colonic SLP, pulmonary SP-A ia major protein ass
ociated with colonic SLP), or small intestinal SLP were injected into the t
ail vein of rats 48 h before, simultaneous with, or 24 h after IA administr
ation. Rats were killed 2 or 10 days after IA was given, their colon or sma
ll intestine was isolated and rinsed, and a segment of colon (10 cm) or sma
ll bowel (30 cm) was weighed and processed for microscopy, NOS and myeloper
oxidase (MPO) activities, and PGE(2) generation. Intracolonic or jejunal IA
resulted after 48 h in extensive macroscopic and microscopic damage, accom
panied by increased segmental weight, MPO and NOS activity, and PGE(2) gene
ration. Colonic SLP antibody administration, either 48 h before or at the t
ime of damage induction, significantly decreased macroscopic as well as mic
roscopic damage, segmental weight, MPO activity, and PGE(2) generation, but
had no effect on NOS activity. Neither control sera nor antisera against S
P-A had any protective effect, nor did injection of anti-colonic SLP antise
ra given 24 h after IA. Small bowel SLP antibody offered no protection agai
nst IA jejunitis, IA-induced colitis but not jejunitis is ameliorated by in
travenous injection of SLP antibody by a mechanism yet to be determined. Th
ese data provide further evidence of a physiologic role for gastrointestina
l SLP.